Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial. [electronic resource]
Producer: 20101123Description: 2438-47 p. digitalISSN:- 1528-0020
- Adolescent
- Adult
- Aged
- Genome
- Germany
- Graft vs Host Disease -- pathology
- Humans
- Leukemia, Lymphocytic, Chronic, B-Cell -- diagnosis
- Lymphocyte Transfusion
- Middle Aged
- Neoplasm, Residual -- diagnosis
- Prognosis
- Prospective Studies
- Stem Cell Transplantation -- methods
- Transplantation Conditioning -- methods
- Transplantation, Homologous -- methods
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.